Scientists have got success with a new injection of HIV. Taking this injection once a year can reduce the risk of HIV ...
HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...
Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...
Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...